Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nrx Pharmaceuticals Inc (NRXP)

Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nrx Pharmaceuticals Inc 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 USA

www.nrxpharma.com P: 484-254-6134

Description:

NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.

Key Statistics

Overview:

Market Capitalization, $K 15,238
Enterprise Value, $K 10,638
Shares Outstanding, K 12,094
Annual Sales, $ 0 K
Annual Net Income, $ -30,150 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,620 K
EBIT, $ -20,480 K
EBITDA, $ -20,470 K
60-Month Beta 1.27
% of Insider Shareholders 19.00%
% of Institutional Shareholders 4.27%
Float, K 9,796
% Float 81.00%
Short Volume Ratio 0.59

Growth:

1-Year Return -57.76%
3-Year Return -98.13%
5-Year Return -98.79%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 11/14/24
Next Earnings Date 11/18/24
Earnings Per Share ttm -2.14
EPS Growth vs. Prev Qtr 80.00%
EPS Growth vs. Prev Year 78.57%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 04/02/24

NRXP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -449.16%
Profit Margin % 0.00%
Debt/Equity -0.19
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.75
Interest Coverage -250.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar